Alpha Tau Medical (DRTS) Liabilities and Shareholders Equity (2020 - 2026)

Alpha Tau Medical has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $108.8 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $108.8 million, up 34.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $430.1 million (up 21.52% YoY), and the FY2025 annual result was $105.7 million, up 22.56% from the prior year.
• Liabilities and Shareholders Equity came in at $108.8 million for Q1 2026 at Alpha Tau Medical, up from $105.7 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $124.0 million in Q2 2022 to a low of $80.9 million in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $107.4 million (2023), against an average of $106.5 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 184.61% in 2022 and declined 21.0% in 2025, its largest moves.
• Alpha Tau Medical's Liabilities and Shareholders Equity stood at $120.1 million in 2022, then fell by 10.62% to $107.4 million in 2023, then fell by 19.73% to $86.2 million in 2024, then rose by 22.56% to $105.7 million in 2025, then increased by 2.95% to $108.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $108.8 million (Q1 2026), $105.7 million (Q4 2025), and $104.7 million (Q3 2025), per Business Quant data.